← Leaderboards
Ellen R Meara
Harvard University (Medical School)
$16,536,227
Attributed
$17,814,895
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
AHRQ$9,329,611 · 1
NIH$8,485,284 · 7
By mechanism
U19$9,329,611 · 1
R01$6,286,466 · 4
P01$1,329,370 · 1
K01$785,323 · 1
R03$84,125 · 1
Top collaborators
- Terri D Lewinson3 shared
- Carrie Hoverman Colla1 shared
Others in their field
Top investigators on “Medicaid”
- David R. Weir · University Of Michigan At Ann Arbor$377,377,642
- Kenneth M Langa · University Of Michigan At Ann Arbor$32,850,148
- Stephen Crystal · Rutgers The St Univ Of Nj New Brunswick$30,600,942
- Reynold Alexander Panettieri · Rutgers Biomedical And Health Sciences$23,582,352
- Duane A. Mitchell · Duke University$22,945,544
- Vincent Mor · Brown University$22,578,425
Research focus
MedicaidHealthcareDesignAffectContractsPharmaceutical PreparationsPaymentLinkVulnerable PopulationsReportingSubstance Use DisorderComplexHealth Care DeliveryPatient CareSurveysBaseCharacteristicsAddictionSafetyDoseOverdoseInpatientsBehavioral HealthAcute
Grant awards (26)
Stemming the Tide: The Role of Payment and Delivery System Reform in Combating the Opioid Epidemic$597,365
R01 · FY2023 · DA
Stemming the Tide: The Role of Payment and Delivery System Reform in Combating the Opioid Epidemic$596,679
R01 · FY2022 · DA
The Causes and Consequences of Risky Prescribing$271,290
P01 · FY2022 · AG · contact PI
PA-20-072: Accelerating the Use of Evidence-based Innovation in Healthcare Systems$2,396,689
U19 · FY2021 · HS · contact PI
Stemming the Tide: The Role of Payment and Delivery System Reform in Combating the Opioid Epidemic$596,014
R01 · FY2021 · DA
The Causes and Consequences of Risky Prescribing$268,501
P01 · FY2021 · AG · contact PI
Stemming the Tide: The Role of Payment and Delivery System Reform in Combating the Opioid Epidemic$767,278
R01 · FY2020 · DA
The Causes and Consequences of Risky Prescribing$268,501
P01 · FY2020 · AG · contact PI
Accelerating the Use of Evidence-based Innovation in Healthcare Systems$3,432,922
U19 · FY2019 · HS · contact PI
The Causes and Consequences of Risky Prescribing$268,501
P01 · FY2019 · AG · contact PI
Accelerating the Use of Evidence-based Innovation in Healthcare Systems$3,500,000
U19 · FY2018 · HS · contact PI
Mental Health Care Under New Payment Strategies$613,303
R01 · FY2018 · MH · contact PI
The Causes and Consequences of Risky Prescribing$252,577
P01 · FY2018 · AG · contact PI
Mental Health Care Under New Payment Strategies$640,571
R01 · FY2017 · MH · contact PI
Mental Health Care Under New Payment Strategies$744,877
R01 · FY2016 · MH · contact PI
Depression Treatment and Substance Abuse$217,394
R01 · FY2013 · DA · contact PI
Depression Treatment and Substance Abuse$232,261
R01 · FY2012 · DA · contact PI
Depression Treatment and Substance Abuse$249,182
R01 · FY2011 · DA · contact PI
Parity, child mental health, and substance abuse$577,941
R01 · FY2010 · DA · contact PI
Parity, child mental health, and substance abuse$453,601
R01 · FY2009 · DA · contact PI
Social Programs, Employment, and Addiction$164,333
K01 · FY2009 · DA · contact PI
Social Programs, Employment, and Addiction$160,919
K01 · FY2008 · DA · contact PI
Social Programs, Employment, and Addiction$156,963
K01 · FY2007 · DA · contact PI
Social Programs, Employment, and Addiction$153,188
K01 · FY2006 · DA · contact PI
Social Programs, Employment, and Addiction$149,920
K01 · FY2005 · DA
RACIAL DISPARITIES AND MEDICARE PREVENTIVE SERVICES$84,125
R03 · FY2003 · AG